[1]印国庆,车文良.冠状动脉非阻塞性心肌梗死的预后及治疗现状[J].国际心血管病杂志,2022,01:5-8.
点击复制
冠状动脉非阻塞性心肌梗死的预后及治疗现状(PDF)
《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]
- 期数:
- 2022年01期
- 页码:
- 5-8
- 栏目:
- 综述
- 出版日期:
- 2022-02-10
文章信息/Info
- Title:
- -
- Author(s):
- -
- 关键词:
- 冠状动脉非阻塞性心肌梗死; 预后; 治疗
- Keywords:
- -
- 分类号:
- -
- DOI:
- 10.3969/j.issn.1673-6583.2022.01.002
- 文献标识码:
- -
- 摘要:
- 冠状动脉非阻塞性心肌梗死（MINOCA）是一组多病因的临床综合征，发病率 在急性心肌梗死中占1%～15%。MINOCA 的病因主要包括心外膜血管病变和微血管病变。 MINOCA 的治疗尚无共识，目前指南推荐在明确病因后给予个体化治疗方案。MINOCA 存 在多种潜在的发病机制，冠状动脉阻塞性心肌梗死（MI-CAD）的二级预防策略对MINOCA 患者是否适用尚不明确。MINOCA 患者发生主要心血管不良事件的风险高于无冠状动脉疾 病的人群，预后并不乐观且危险因素尚不明确。
- Abstract:
- -
参考文献/References
[1] Tamis-Holland JE, Jneid H. Myocardial infarction with
nonobstructive coronary arteries (MINOCA): It's time to face
reality![J]. J Am Heart Assoc, 2018, 7(13):e009635.
[2] Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal
definition of myocardial infarction (2018)[J]. Kardiol Pol,
2018, 76(10):1383-1415.
[3] Collet JP, Thiele H, Barbato E, et al. 2020 ESC guidelines
for the management of acute coronary syndromes in patients
presenting without persistent ST-segment elevation[J]. Eur
Heart J, 2021, 42(14):1289-1367.
[4] Safdar B, Spatz ES, Dreyer RP, et al. Presentation, clinical
profile, and prognosis of young patients with myocardial
infarction with nonobstructive coronary arteries (MINOCA):
results from the Virgo study[J]. J Am Heart Assoc, 2018,
7(13):e009174.
[5] Pasupathy S, Air T, Dreyer RP, et al. Systematic review of
patients presenting with suspected myocardial infarction
and nonobstructive coronary arteries[J]. Circulation, 2015,
131(10):861-807.
[6] Abdu F, Liu L, Mohammed AQ, et al. Myocardial infarction
with non-obstructive coronary arteries (MINOCA) in Chinese
patients: clinical features, treatment and 1 year follow-up[J].
Int J Cardiol, 2019, 287:27-31.
[7] Gu XH, He CJ, Shen L, et al. Association between depression
and outcomes in Chinese patients with myocardial infarction
and nonobstructive coronary arteries[J]. J Am Heart Assoc,
2019, 8(5):e011180.
[8] Tamis-Holland JE, Jneid H, Reynolds HR, et al. Contemporary
diagnosis and management of patients with myocardial
infarction in the absence of obstructive coronary artery
disease: a scientific statement from the American heart
association[J]. Circulation, 2019, 139(18):e891-e908.
[9] Sucato V, Testa G, Puglisi S, et al. Myocardial infarction with
non-obstructive coronary arteries (MINOCA): intracoronary
imaging-based diagnosis and management[J]. J Cardiol, 2021,
77(5):444-451.
[10] Choo EH, Chang K, Lee KY, et al. Prognosis and predictors
of mortality in patients suffering myocardial infarction with
non-obstructive coronary arteries[J]. J Am Heart Assoc, 2019,
8(14):e011990.
[11] Lindahl B, Baron T, Erlinge D, et al. Medical therapy for
secondary prevention and long-term outcome in patients with
myocardial infarction with nonobstructive coronary artery
disease[J]. Circulation, 2017, 135(16):1481-1489.
[12] Ishii M, Kaikita K, Sato K, et al. Impact of aspirin on the
prognosis in patients with coronary spasm without significant
atherosclerotic stenosis[J]. Int J Cardiol, 2016, 220:328-332.
[13] Paolisso P, Bergamaschi L, Saturi G, et al. Secondary
prevention medical therapy and outcomes in patients with
myocardial infarction with non-obstructive coronary artery
disease[J]. Front Pharmacol, 2019, 10:1606.
[14] Bossard M, Gao P, Boden W, et al. Antiplatelet therapy
in patients with myocardial infarction without obstructive
coronary artery disease[J]. Heart, 2021, 107(21):1739-1747.
[15] Cespon FM, Abu-Assi E, Raposeiras RS, et al. Cardiovascular
mortality in patients with MINOCA and prognostic effect of
statin treatment[J]. Eur Heart J, 2019, 40(Suppl 1):ehz747.
[16] Dreyer RP, Tavella R, Curtis JP, et al. Myocardial infarction
with non-obstructive coronary arteries as compared with
myocardial infarction and obstructive coronary disease:
outcomes in a medicare population[J]. Eur Heart J, 2020,
41(7):870-878.
[17] Gasior P, Desperak A, Gierlotka M, et al. Clinical
characteristics, treatments, and outcomes of patients with
myocardial infarction with non-obstructive coronary arteries
(MINOCA): results from a multicenter national registry[J]. J
Clin Med, 2020, 9(9):2779.
[18] Kang WY, Jeong MH, Ahn YK, et al. Are patients with
angiographically near-normal coronary arteries who present
as acute myocardial infarction actually safe?[J]. Int J Cardiol,
2011, 146(2):207-212.
[19] Pizzi C, Xhyheri B, Costa GM, et al. Nonobstructive versus
obstructive coronary artery disease in acute coronary
syndrome: a meta-analysis[J]. J Am Heart Assoc, 2016,
5(12):e004185.
[20] Raparelli V, Elharram M, Shimony A, et al. Myocardial
infarction with no obstructive coronary artery disease:
angiographic and clinical insights in patients with premature
presentation[J]. Can J Cardiol, 2018, 34(4):468-476.
[21] Nordenskj?ld AM, Lagerqvist B, Baron T, et al. Reinfarction
in patients with myocardial infarction with nonobstructive
coronary arteries (MINOCA): coronary findings and
prognosis[J]. Am J Med, 2019, 132(3):335-346.
[22] Ishii M, Kaikita K, Sakamoto K, et al. Characteristics and
inhospital mortality of patients with myocardial infarction in
the absence of obstructive coronary artery disease in superaging
society[J]. Int J Cardiol, 2020, 301:108-113.
[23] Williams M, Barr PR, Lee M, et al. Outcome after myocardial
infarction without obstructive coronary artery disease[J].
Heart, 2019, 105(7):524-530.
[24] Eggers KM, Hjort M, Baron T, et al. Morbidity and causespecific
mortality in first-time myocardial infarction with
nonobstructive coronary arteries[J]. J Intern Med, 2019,
285(4):419-428.
[25] Bainey KR, Welsh RC, Alemayehu WA, et al. Populationlevel
incidence and outcomes of myocardial infarction with
non-obstructive coronary arteries (MINOCA): insights from
the Alberta contemporary acute coronary syndrome patients
invasive treatment strategies (COAPT) study[J]. Int J Cardiol,
2018, 264:12-17.
[26] Ciliberti G, Coiro S, Tritto I, et al. Predictors of poor clinical
outcomes in patients with acute myocardial infarction and
non-obstructed coronary arteries (MINOCA)[J]. Int J Cardiol,
2018, 267:41-45.
[27] Pelliccia F, Pasceri V, Niccoli G, et al. Predictors of mortality
in myocardial infarction and nonobstructed coronary arteries:
a systematic review and meta-regression[J]. Am J Med, 2020,
133(1):73-83.
[28] Hjort M, Lindahl B, Baron T, et al. Prognosis in relation to
high-sensitivity cardiac troponin T levels in patients with
myocardial infarction and non-obstructive coronary arteries[J].
Am Heart J, 2018, 200:60-66.
[29] Nordenskjold AM, Baron T, Eggers KM, et al. Predictors of
adverse outcome in patients with myocardial infarction with
non-obstructive coronary artery (MINOCA) disease[J]. Int J
Cardiol, 2018, 261:18-23.
[30] Xu B, Abdu F, Liu L, et al. Clinical outcomes and predictors
of ST-elevation versus non-ST-elevation myocardial infarction
with Non-Obstructive coronary arteries[J]. Am J Med Sci,
2020, 360(6):686-692.
备注/Memo
- 备注/Memo:
-
基金项目：中央高校基础研究基金（2212010211）；上海市崇明区“可
持续发展科技创新行动计划”项目（CKY2020-29）
通信作者：车文良， E-mail:chewenliang@tongji.edu.cn
常用功能
统计/Statistics
- 摘要浏览/Viewed1
- 全文下载/Downloads355
- 评论/Comments
